Clinical trials

  • DURVALUMAB for Pulmonary large-cell neuroendocrine carcinoma (LCNEC) — metastatic
  • OXYTOCIN for Benzodiazepine dependence
  • DOTATATE, COPPER (64CU) CHLORIDE for Neuroendocrine neoplasms | Gastroenteropancreatic neuroendocrine tumor
  • linaprazan glurate for Erosive gastroesophageal reflux disease | Gastroesophageal reflux
  • Brentuximab vedotin for Classical Hodgkin lymphoma | Hodgkin lymphoma
  • INDOCYANINE GREEN for Thyroid diseases | Hypoparathyroidism | Hypocalcemia
  • ALTEPLASE for Acute pulmonary embolism (intermediate-high risk)
  • TRASTUZUMAB EMTANSINE for HER2-positive breast cancer | Advanced breast cancer | Metastatic breast cancer
  • TIRATRICOL for Monocarboxylate transporter 8 (MCT8) deficiency
  • BELANTAMAB MAFODOTIN for Relapsed/refractory multiple myeloma | Multiple myeloma
  • Temozolomide for Neuroblastoma (relapsed, high-risk)
  • DEUCRICTIBANT for Hereditary angioedema